AAGH (America Great Health) Gross Margin %: 82.22% (As of Dec. 2025) — 68% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is America Great Health Gross Margin %?

America Great Health AAGH Gross Margin % is 82.22% as of Dec. 2025, which is 68% above its 10-year median of 48.82. The stock has 4 warning signs investors should review. Among 733 Biotechnology companies, America Great Health ranks better than 59.89% on this metric.

Gross Margin % is calculated as gross profit divided by its revenue. America Great Health's Gross Profit for the three months ended in Dec. 2025 was $0.04 Mil. America Great Health's Revenue for the three months ended in Dec. 2025 was $0.05 Mil. Therefore, America Great Health's Gross Margin % for the quarter that ended in Dec. 2025 was 82.22%.


The historical rank and industry rank for America Great Health's Gross Margin % or its related term are showing as below:

AAGH' s Gross Margin % Range Over the Past 10 Years
Min: -1413.33   Med: 48.82   Max: 86.48
Current: 70.31


During the past 13 years, the highest Gross Margin % of America Great Health was 86.48%. The lowest was -1413.33%. And the median was 48.82%.

AAGH's Gross Margin % is ranked better than
59.89% of 733 companies
in the Biotechnology industry
Industry Median: 60.9 vs AAGH: 70.31

America Great Health had a gross margin of 82.22% for the quarter that ended in Dec. 2025 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for America Great Health was 0.00% per year.


America Great Health  (OTCPK:AAGH) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

America Great Health had a gross margin of 82.22% for the quarter that ended in Dec. 2025 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


America Great Health Gross Margin % Related Terms


America Great Health Gross Margin % Historical Data

* Premium members only.

The historical data trend for America Great Health's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

America Great Health Gross Margin % Chart

America Great Health Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 26.02 -1,413.33 82.84 57.63 86.48

America Great Health Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 91.21 89.29 73.33 60.11 82.22

AAGH vs ADTX, PKTX, BBLG: Gross Margin % Comparison

For the Biotechnology subindustry, America Great Health's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


America Great Health Gross Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, America Great Health's Gross Margin % distribution charts can be found below:

* The bar in red indicates where America Great Health's Gross Margin % falls into.



America Great Health Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

America Great Health's Gross Margin for the fiscal year that ended in Jun. 2025 is calculated as

Gross Margin % (A: Jun. 2025 )=Gross Profit (A: Jun. 2025 ) / Revenue (A: Jun. 2025 )
=0.3 / 0.392
=(Revenue - Cost of Goods Sold) / Revenue
=(0.392 - 0.053) / 0.392
=86.48 %

America Great Health's Gross Margin for the quarter that ended in Dec. 2025 is calculated as


Gross Margin % (Q: Dec. 2025 )=Gross Profit (Q: Dec. 2025 ) / Revenue (Q: Dec. 2025 )
=0 / 0.045
=(Revenue - Cost of Goods Sold) / Revenue
=(0.045 - 0.008) / 0.045
=82.22 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Frequently Asked Questions Learn more about Gross Margin % →
What does a Gross Margin % of 82.22% mean?
America Great Health (AAGH) has a Gross Margin % of 82.22% as of Dec. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on America Great Health and its competitors. This is 68% above median its historical median of 48.82. According to the industry distribution chart, America Great Health ranks #294 out of 733 companies in the Biotechnology industry, placing it in the top 40.1%.
Is America Great Health's Gross Margin % too high?
America Great Health's current Gross Margin % of 82.22% is 68% above median its 10-year median of 48.82. The Biotechnology industry median Gross Margin % is 60.90. America Great Health's value of 82.22% is 35% above this industry median. Based on the distribution chart, America Great Health ranks #294 out of 733 companies in the Biotechnology industry, which is above the industry midpoint.
How does America Great Health's Gross Margin % compare to ADTX and PKTX?
According to the Biotechnology industry distribution chart, America Great Health ranks #294 out of 733 companies for Gross Margin %. This puts America Great Health in the upper half of its industry. The industry median Gross Margin % is 60.90. America Great Health's value of 82.22% is 35% above this benchmark. While the company's 10-year median is 48.82 vs. the industry median of 60.90, America Great Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Biotechnology company?
The median Gross Margin % among Biotechnology companies is 60.90, based on 733 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. America Great Health's current Gross Margin % of 82.22% is 35% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on America Great Health and its competitors. For the Biotechnology industry, the median Gross Margin % is 60.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. America Great Health's current Gross Margin % is 82.22%, which is 68% above median its own 10-year median of 48.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is America Great Health stock overvalued right now?
America Great Health (AAGH) has a current Gross Margin % of 82.22%. The current Gross Margin % is 82.22%, which is 68% above median its 10-year median of 48.82 and 35% above the Biotechnology industry median of 60.90. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For America Great Health (AAGH), the current Gross Margin % is 82.22% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

America Great Health Business Description

Address 1609 W Valley Boulevard, Unit 338A, Alhambra, CA, USA, 91803
America Great Health operates as a biotechnology company. The company focuses on protein and peptide small molecular drugs research and development, diagnostic and medical devices with AI cloud computing, cell therapy, and regenerative medicine and supplements, as well as invests in technologies and integrates with business development for the healthcare ecosystem.